Tatva Chintan Pharma Chem Limited (NSE:TATVA)

Market Cap	27.06B
Revenue (ttm)	4.80B
Net Income (ttm)	327.63M
Shares Out	23.39M
EPS (ttm)	14.02
PE Ratio	82.51
Forward PE	44.08
Dividend	1.00 (0.08%)
Ex-Dividend Date	Sep 12, 2025

Volume	265,328
Average Volume	109,328
Open	1,294.00
Previous Close	1,273.20
Day's Range	1,145.80 - 1,294.00
52-Week Range	621.00 - 1,610.00
Beta	0.33
RSI	32.06
Earnings Date	Jan 21, 2026

About Tatva Chintan Pharma Chem

Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal car...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1996
• Employees: 679
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: TATVA

Financial Performance

In 2024, Tatva Chintan Pharma Chem's revenue was 3.83 billion, a decrease of -2.74% compared to the previous year's 3.94 billion. Earnings were 57.13 million, a decrease of -81.18%.